BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang L, Yang Z, Huang W, Wu J. H19 potentiates let-7 family expression through reducing PTBP1 binding to their precursors in cholestasis. Cell Death Dis 2019;10:168. [PMID: 30778047 DOI: 10.1038/s41419-019-1423-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Liu R. Long non-coding RNA H19 in the liver-gut axis: A diagnostic marker and therapeutic target for liver diseases. Experimental and Molecular Pathology 2020;115:104472. [DOI: 10.1016/j.yexmp.2020.104472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Han S, Zhang T, Kusumanchi P, Huda N, Jiang Y, Yang Z, Liangpunsakul S. Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease. Clin Mol Hepatol 2020;26:705-14. [PMID: 33053941 DOI: 10.3350/cmh.2020.0166] [Reference Citation Analysis]
3 Jiang X, Ning Q. The mechanism of lncRNA H19 in fibrosis and its potential as novel therapeutic target. Mechanisms of Ageing and Development 2020;188:111243. [DOI: 10.1016/j.mad.2020.111243] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
4 Ma Y, Harris J, Li P, Cao H. Long noncoding RNAs-a new dimension in the molecular architecture of the bile acid/FXR pathway. Mol Cell Endocrinol 2021;525:111191. [PMID: 33539963 DOI: 10.1016/j.mce.2021.111191] [Reference Citation Analysis]
5 Yamaguchi Y, Tayama C, Tomikawa J, Akaishi R, Kamura H, Matsuoka K, Wake N, Minakami H, Kato K, Yamada T, Nakabayashi K, Hata K. Placenta-specific epimutation at H19-DMR among common pregnancy complications: its frequency and effect on the expression patterns of H19 and IGF2. Clin Epigenetics 2019;11:113. [PMID: 31370882 DOI: 10.1186/s13148-019-0712-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Park KS, Rahat B, Lee HC, Yu ZX, Noeker J, Mitra A, Kean CM, Knutsen RH, Springer D, Gebert CM, Kozel BA, Pfeifer K. Cardiac pathologies in mouse loss of imprinting models are due to misexpression of H19 long noncoding RNA. Elife 2021;10:e67250. [PMID: 34402430 DOI: 10.7554/eLife.67250] [Reference Citation Analysis]
7 Agostini M, Ganini C, Candi E, Melino G. The role of noncoding RNAs in epithelial cancer. Cell Death Discov 2020;6:13. [PMID: 32194993 DOI: 10.1038/s41420-020-0247-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
8 Lightbody RJ, Taylor JMW, Dempsie Y, Graham A. Induction of microRNA hsa-let-7d-5p, and repression of HMGA2, contribute protection against lipid accumulation in macrophage 'foam' cells. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:159005. [PMID: 34274506 DOI: 10.1016/j.bbalip.2021.159005] [Reference Citation Analysis]
9 Gui W, Zhu WF, Zhu Y, Tang S, Zheng F, Yin X, Lin X, Li H. LncRNAH19 improves insulin resistance in skeletal muscle by regulating heterogeneous nuclear ribonucleoprotein A1. Cell Commun Signal 2020;18:173. [PMID: 33115498 DOI: 10.1186/s12964-020-00654-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Song Y, Tran M, Wang L, Shin DJ, Wu J. MiR-200c-3p targets SESN1 and represses the IL-6/AKT loop to prevent cholangiocyte activation and cholestatic liver fibrosis. Lab Invest 2021. [PMID: 34880414 DOI: 10.1038/s41374-021-00710-6] [Reference Citation Analysis]
11 Wu J, Nagy LE, Wang L. The long and the small collide: LncRNAs and small heterodimer partner (SHP) in liver disease. Mol Cell Endocrinol 2021;528:111262. [PMID: 33781837 DOI: 10.1016/j.mce.2021.111262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yang Z, Liu Z, Yang Y, Dai Y, Gao X. Polypyrimidine tract-binding protein 1 regulates the Sertoli cell blood-testis barrier by promoting the expression of tight junction proteins. Exp Ther Med 2021;22:847. [PMID: 34149893 DOI: 10.3892/etm.2021.10279] [Reference Citation Analysis]
13 Briata P, Gherzi R. Long Non-Coding RNA-Ribonucleoprotein Networks in the Post-Transcriptional Control of Gene Expression. Noncoding RNA 2020;6:E40. [PMID: 32957640 DOI: 10.3390/ncrna6030040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Li J, Cao LT, Liu HH, Yin XD, Wang J. Long non coding RNA H19: An emerging therapeutic target in fibrosing diseases. Autoimmunity 2020;53:1-7. [PMID: 31646913 DOI: 10.1080/08916934.2019.1681983] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
15 Yang Z, Zhang T, Han S, Kusumanchi P, Huda N, Jiang Y, Liangpunsakul S. Long noncoding RNA H19 - a new player in the pathogenesis of liver diseases. Transl Res 2021;230:139-50. [PMID: 33227504 DOI: 10.1016/j.trsl.2020.11.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Xu F, Zhong J, Guo B, Lin X, Wu F, Li F, Shan S, Zheng M, Wang Y, Xu Q, Lei L, Tan C, Liao X, Yuan L. H19 Promotes Osteoblastic Transition by Acting as ceRNA of miR-140-5p in Vascular Smooth Muscle Cells. Front Cell Dev Biol 2022;10:774363. [DOI: 10.3389/fcell.2022.774363] [Reference Citation Analysis]
17 Zhang C, Zhang X, Wang J, Di F, Xue Y, Lin X, Zhang Y, Zhang H, Zhang Z, Gu Y. Lnc00462717 regulates the permeability of the blood-brain tumor barrier through interaction with PTBP1 to inhibit the miR-186-5p/Occludin signaling pathway. FASEB J 2020;34:9941-58. [PMID: 32623796 DOI: 10.1096/fj.202000045R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Wang Y, Hylemon PB, Zhou H. Long Noncoding RNA H19: A Key Player in Liver Diseases. Hepatology 2021. [PMID: 33630308 DOI: 10.1002/hep.31765] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Gundermann DG, Martínez J, De Kervor G, González-Pinto K, Larraín J, Faunes F. Overexpression of Lin28a delays Xenopus metamorphosis and down-regulates albumin independently of its translational regulation domain. Dev Dyn 2019;248:969-78. [PMID: 31397023 DOI: 10.1002/dvdy.98] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Li H, Shen S, Ruan X, Liu X, Zheng J, Liu Y, Yang C, Wang D, Liu L, Ma J, Ma T, Wang P, Cai H, Li Z, Zhao L, Xue Y. Biosynthetic CircRNA_001160 induced by PTBP1 regulates the permeability of BTB via the CircRNA_001160/miR-195-5p/ETV1 axis. Cell Death Dis 2019;10:960. [PMID: 31862871 DOI: 10.1038/s41419-019-2191-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
21 Dai S, Wang C, Zhang C, Feng L, Zhang W, Zhou X, He Y, Xia X, Chen B, Song W. PTB: Not just a polypyrimidine tract-binding protein. J Cell Physiol 2022. [PMID: 35288937 DOI: 10.1002/jcp.30716] [Reference Citation Analysis]
22 Guiyu S, Quan N, Ruochen W, Dan W, Bingnan C, Yuanyua L, Yue B, Feng J, Chong Q, Leilei W. LncRNA-SNX17 Promotes HTR-8/SVneo Proliferation and Invasion Through miR-517a/IGF-1 in the Placenta of Diabetic Macrosomia. Reprod Sci 2021. [PMID: 34270000 DOI: 10.1007/s43032-021-00687-z] [Reference Citation Analysis]
23 Chen MJ, Deng J, Chen C, Hu W, Yuan YC, Xia ZK. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis. Int J Biochem Cell Biol 2019;113:27-36. [PMID: 31102664 DOI: 10.1016/j.biocel.2019.05.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 6.7] [Reference Citation Analysis]